ProMort

The ProMort research program is a multi-disciplinary, international research project aiming to develop new, high-performing prognostic tools for prostate cancer that can be implemented in clinical practice and help tailoring the right treatment to the right patient. The program is run in collaboration between KI, Harvard (USA), CRS4 (Italy), University of Turin (Italy), Örebro University Hospital, and the Swedish Prostate Cancer Register (NPCR). Specifically, ProMort aims to 1) identify molecular factors associated with prostate cancer death, using tumor tissue from diagnostic biopsies; 2) identify novel histopathological features associated with prostate cancer death using standard pathological review and artificial intelligence (AI); 3) improve prognostication in prostate cancer by combining clinical variables with the outcomes of aims 1-2 in a new prognostic tool.